
EU CTIS: Europe’s New Clinical Trial Information System Blog Post
The EU CTIS is now fully implemented, replacing EudraCT as the central hub for clinical trial submissions, approvals, and compliance under EU-CTR.
The EU CTIS is now fully implemented, replacing EudraCT as the central hub for clinical trial submissions, approvals, and compliance under EU-CTR.
Pharmaceutical companies are being required to be more transparent through the timely disclosure of more clinical trial data on more registry platforms such as Clinicaltrials.gov in the US and CTIS…
Our tech-enabled clinical disclosure services ensure global regulatory compliance, supporting clear communication and trust in drug development.
Our regulatory writing services offer expertly crafted, high-quality documents for drug development, ensuring compliance and timely submissions.